In the competitive field of Bone Drugs, companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top opposing and opposed companies, and the most recent patents getting opposed. Stay informed on the latest developments in Bone Drugs technology and learn how to protect your intellectual property.

Latest patents opposed in the Bone Drugs industry

Patent challenges are becoming increasingly common in the Bone Drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Bone Drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Bone Drugs industry

EP4084799Use Of Nmn For The Prevention And/Or Treatment Of Joint Pain Induced By Physical Activity, And Corresponding CompositionsNUVAMID SAMay 30, 2024SCHLICH LTD
EP3432890Product, In Particular Nutritional Supplement, Animal Feed, Foodstuff, Drug, Cosmetic And/Or Animal Feed Supplement For Supplying At Least One Molecule That Bonds To A Vitamin D Receptor, And Method For The Production ThereofBÜTER, BERNDApr 12, 2024HERBONIS ANIMAL HEALTH GMBH
EP3485890Treatment Of Metabolic Disorders In Canine AnimalsBOEHRINGER INGELHEIM VETMEDICA GMBHFeb 9, 2024CEVA SANTE ANIMALE
EP3738585Direct Compression Formulation And ProcessNOVARTIS AGSep 11, 2023HERZOG IP PATENTANWALTS GMBH
EP3516966A Concentrated Krill Protein Hydrolysate FractionRIMFROST TECHNOLOGIES ASAug 29, 2023AKER BIOMARINE UNDERSTORY AS
EP3302437Stable Cannabinoid FormulationsFRESH CUT DEVELOPMENT, LLCAug 9, 2023CARDIOL THERAPEUTICS INC.
EP3345607Methods Of Altering Bone Growth By Administration Of Sost Or Wise Antagonist Or AgonistOSSIFI-MAB LLCJul 26, 2023J A KEMP LLP
EP2397142Use Of Dpp Iv InhibitorsBOEHRINGER INGELHEIM PHARMA GMBH & CO. KGApr 27, 2023GENERICS UK
EP2397142Use Of Dpp Iv InhibitorsBOEHRINGER INGELHEIM INTERNATIONAL GMBHApr 26, 2023STADA
EP2397142Use Of Dpp Iv InhibitorsBOEHRINGER INGELHEIM PHARMA GMBH & CO. KGApr 25, 2023KRAUS & LEDERER PARTGMBB

To stay ahead in the competitive Bone Drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the Bone Drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Patent NumberGrant DateTitleApplicantTotal Oppositions
EP2968155Mar 3, 2021Tofacitinib Oral Sustained Release Dosage FormsPFIZER INC.6
EP3366283Sep 1, 2021Direct Compression Formulation And ProcessNOVARTIS AG6
EP2397142Jul 27, 2022Use Of Dpp Iv InhibitorsBOEHRINGER INGELHEIM PHARMA GMBH & CO. KG5
EP3345607Oct 26, 2022Methods Of Altering Bone Growth By Administration Of Sost Or Wise Antagonist Or AgonistOSTEOQC INC.4
EP2907522Aug 2, 2017Method Of Increasing Bone Toughness And Stiffness And Reducing FracturesELI LILLY AND COMPANY3
EP3204047May 27, 2020Calcifediol Soft CapsulesFAES FARMA, S.A.3
EP3293202Feb 7, 2024Anti Human Interleukin-1 Receptor Accessory Protein (Il1Rap) Antibodies And Uses ThereofCANTARGIA AB3
EP2582683Mar 21, 2018Treatment Of Gout And HyperuricemiaARDEA BIOSCIENCES, INC.3
EP2776129Jun 17, 2020Calcimimetics And Methods For Their UseKAI PHARMACEUTICALS, INC.2
EP2305711Aug 2, 2017Methods For Treating Osteoarthitis Pain By Administering A Nerve Growth Factor Antagonist And Compositions Containing The SameRINAT NEUROSCIENCE CORP.2